Private-Label Peptide Vials: A Project Checklist

Identify whether the vial contains a single peptide or a cosmetic blend. Specify gross fill and peptide content separately. If a companion cosmetic liquid is included, define its composition, purpose and evaluation requirements as a separate part of the kit.

Vial capacity, material, closure and pack protection affect handling and the consumer or professional presentation. Discuss the intended storage and shipment conditions with the packaging brief. A premium-looking box should still protect the product and support the necessary identification information.

Treat the vial as a system containing material, closure and instructions. A milligram number alone cannot describe that system. Specify whether a companion component is included and who approves its composition. If the pack is for cosmetic formulation work, the wording and presentation must stay within that purpose; a vial format does not establish suitability for injection or a ready-to-use consumer product.

Check ingredient naming, quantity statements, batch coding and any storage instructions before printing. The artwork should use the same approved composition and market-specific review as the technical file. Do not let a design proof become the place where new unsupported claims are introduced.

Agree which samples, files and batch documents will be supplied for approval. Keep production artwork and the technical specification under revision control. For a repeat order, confirm whether any ingredient, packaging or process detail has changed since the last approved run.

Create an artwork-to-specification cross-check. Each printed identity, quantity and handling statement should trace to an approved field. Record the artwork version and a named sign-off before packaging procurement. For a first run, request the proposed pack specification and sample presentation together so a change in vial dimensions, label area or closure is discovered before the commercial material is committed.